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In the first part of this review similarities and differences between physiological and pathological biomineralization (bone and 
tooth formation, osteoarticular and tooth pathologies, urolithiasis) are discussed. Both processes may be seen as the deposition 
of ionic crystals from high ionic strength solutions upon / within a preformed organic matrix and the presence or deficiency of 
crystallization promoters or inhibitors plays a decisive role. However, while physiological mineralization is strictly biologically 
controlled, urolithiasis is more likely driven by physicochemical factors, such as urinary supersaturation and lack of inhibitors 
of crystallization and aggregation.
In the second part of the review physicochemical research, performed to facilitate understanding of biomineralization processes 
is described. It comprises precipitation diagrams for calcium and magnesium phosphates, calcium oxalates, uric acid, sodium 
and calcium urates, precipitating from high ionic strength solutions at biologically relevant conditions. Here we present a general 
precipitation diagram of the calcium phosphate system, in which the precipitation boundary and the boundary between the regions 
of direct crystallization and crystallization via precursor phases are defined by the mean ion activity products and the pH. Kinetic 
diagrams of spontaneously precipitating systems are represented, which may be interpreted in terms of subsequent or parallel 
precipitation processes, such as nucleation, crystal growth and aggregation. The dual role of macromolecules, poly-L-glutamate 
and poly-L-lysine, as crystallization promoters and/or inhibitors is demonstrated by a kinetic study of the phase transformation 
of amorphous calcium phosphate, ACP, into octacalcium phosphate and/or apatite. It is shown that the polyelectrolytes at low 
concentrations induce and at higher concentrations inhibit secondary precipitation of the crystalline phase. 
 In the third part of the review applied interdisciplinary research is described. Three chemical methods for testing the inhibitory 
potential of whole urine were developed. The methods are simple and can be used in a clinical laboratory for discrimination 
between urines of calcium stone formers and healthy persons. Furthermore a new class of biomimetic organic-inorganic 
composites, as coatings for bioinert metal implants was recently developed. The coating procedure involves “in situ” growth of 
calcium phosphate crystals within an organic - inorganic matrix, the inorganic part being ACP. The coatings are tightly anchored 
to the substrate and exhibit excellent biological properties as verified by in vitro testing and animal experiments.
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 Introduction
Osteoarticular pathologies such as traumas, child growth 
defects, osteoarthritis, osteoporosis and related failures are, at 
all ages, a serious cause of handicap and concern in public 
healthcare. Bone diseases and induced defects are also of 
prime importance in maxillo-facial surgery and odontology 
especially for aging populations.
Other related serious health problems that need to be 
addressed are calcifications occurring in soft tissues, such as 
urinary and kidney stones, some forms of arteriosclerosis and 
related diseases. Urolithiasis, i.e. the formation of urinary and 
kidney stones presents a particularly important medical and 
social problem because of its debilitating effects and high rate 
of recurrence among working age populations. 
This review is focused on interdisciplinary research carried 
out with the purpose of (a) designing substitute materials 
for bone and/or cartilage regeneration and (b) prevention of 
soft tissue mineralization, specifically urinary and kidney 
stone formation. Similarities and differences between the 
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two problems are discussed and it is shown that progress can 
only be made by close collaboration between medical doctors, 
materials scientists, cell and molecular biologists.
1. The mechanisms of physiological and pathological 
mineralization:  
The first step in any research on mineralized tissues should be 
the understanding of the basic mechanisms of physiological 
and pathological mineralization. 
1.1 Physiological mineralization: Bone and teeth are precisely 
organized organic – inorganic nanocomposites, the main 
components of which are listed in Table 1. Bone and dentin 
are characteristically composed of type I collagen fibrils, 
which comprise about 85 -90% of the organic matrix and are 
intimately associated with precisely oriented apatite nano-
crystals (1, 2). Additional minor components include an 
array of noncollageneous macromolecules (proteoglycans, 
acidic and/or phosphorylated glycoproteins) which have been 
found to have a decisive role in the mineralization process. 
In fact it has been assumed that collagen fiber networks 
provide the organizational framework and spatial constraint 
for crystal deposition, whereas noncollageneous, acidic and/
or phosphorylated matrix macromolecules are involved in the 
control of nucleation and growth of the mineral phase (1, 3, 4).
 
The first step in controlled mineralization is the secretion of 
the organic matrix by specialized cells (i.e. osteoblast and 
odontoblast for bone and dentin respectively).  The subsequent 
process of mineralization of the organic matrix is still being 
considered with several possible mechanisms being discussed.
 
The source of ions for mineralization is the blood serum, 
TABLE 1. 
The main components of bone, dentin and tooth enamel as organic-inorganic composites.
TABLICA 1. 









collagen - kolagen 
+ proteoglycans + 
+ acidic proteins + 
+ proteoglikani + 







osteoblast, odontoblast cells - stanice osteoblast, odontoblast 
which is a well defined, high ionic strength (I = 0.15) aqueous 
solution just slightly supersaturated and metastable with 
regard to calcium phosphate crystallization (Table 2, column 
A). It is therefore inconceivable that blood serum itself 
would induce homogeneous nucleation of hydroxyapatite 
crystals. It may be assumed that multiple mechanisms 
initiating mineralization are possible, which at times may act 
synergistically to boost extracellular matrix mineralization 
when necessary (5). Mineralization may be induced either 
locally by heterogeneous nucleation at specific sites, mediated 
by acidic or phosphorylated matrix macromolecules (3, 4) or 
by homogeneous nucleation within matrix vesicles, which can 
actively concentrate calcium and phosphate ions by enzymatic 
activity and thus acquire mineral in the form of amorphous 
calcium phosphate, ACP or poorly crystalline apatite. (6). The 
involvement of matrix vesicles (7) and/or amorphous calcium 
phosphate precursors (8) in certain forms of biomineralization 
has been demonstrated.
1.2 Osteoarticular pathologies and tooth defects: Whether 
induced by trauma or disease these pathologies can cause small 
or large defects in the skeleton. In the case of small defects 
it may be possible to fill the voids with suitable composite 
materials, which, if based on reverse thermoreversible gels 
may be injectible (M. Dutour Sikirić, A. Sosnik, D. Cohn and 
H. Fűredi-Milhofer, unpublished results). However, in the case 
of large defects the need arises for surgical replacement and/
or repair of mineralized tissues with load bearing applications 
(such as hip replacement, tooth implants). This need led to 
extensive research with the aim to design substitute materials 
that mimic mineralized tissue’s mechanical, chemical, 
biological and functional properties. An attractive solution is 
to use metals with the required biomechanical properties, such 
as titanium, titanium alloys, zirconium and/or its alloys, etc. 
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TABLE 2. 
Ionic concentrations in blood serum and in 24h urine (mean values obtained from 20 male patients, after ref. (12). 
TABLICA 2. 
Ionske koncentracije u krvnom serumu i 24 satnom urinu (srednje vrijednosti dobivene na uzorku od 20 muških pacijenata, 
prema ref. (12).
ion - molecule 
ion - molekula 
blood serum 




K+ 5.0 45.9 ±13.0 
Mg2+ 1.5  
Ca2+ 2.5 7.3 ±2.7 
HCO3- 27.0  
HPO42- 1.0 30.7 ±8.8 
SO42- 0.5  
pH 7.5 5.9 ±0.8 
NaCl 150.0 202.1 ±65.9 
C2O42-  0.28 ±0.20 
citrate / citrat  1.0 ± 0.8 
urate / urat  3.8 ±1.2 
creatinin / kreatinin  15.2±2.9 
urinary volume / volumen urina  1434.6 ±503.3 
 
In order to successfully integrate such materials into the body; 
they may be covered with biocompatible and/or preferably 
bioactive coatings. (9).
1.3 Soft tissue mineralization - urolithiasis: In contrast to 
the mineralization of bone and teeth, which is due to strictly 
controlled biological mechanisms, in urolithiasis the first step 
is the formation of crystals within the urine, which depends 
on physicochemical factors, such as urinary supersaturation, 
deficiency of inhibitors, etc (10). The urine is a complex 
system with variable flow rate, pH (5 – 7), high ionic strength 
(0.33 mol/l (11)) and variable composition. It is usually 
supersaturated with regard to one or more of the urinary salts. 
As an example in Table 2 column B are listed the mean values 
and standard deviations of the main urinary parameters in 24h 
urine samples from 20 male stone formers from the Osijek 
region (12). An analysis of the frequency of occurrence of 
abnormal metabolic parameters in this group showed that 
35 % of patients had hypercalciuria, 15% had hyperoxaluria, 
36% hyperuricosuria, 15% hyperphosphaturia and 25% had 
hypocitraturia.
It seems that urinary supersaturation is a necessary, but not 
sufficient condition for urolithiasis to occur. Even though it 
almost always results in the voiding of crystals (crystaluria) 
(13), this does not necessarily always lead to renal stone 
growth. Other properties of the urine and the urinary tract, 
such as the presence or absence of inhibitors of crystal growth 
and/or aggregation and the attachment of crystals or crystal 
aggregates to the renal walls must also be taken into account. 
It has been suggested (11) that a protective layer consisting of 
glycosaminoglycans covers the internal renal walls in healthy 
kidneys and that crystal attachment with subsequent stone 
growth is restricted to areas with a defective layer. 
2. Physicochemical background:
 
2.1. The conditions of precipitation of biomineral from high 
ionic strength aqueous solutions. Precipitation diagrams and 
kinetics. Both physiological and pathological mineralization 
involves crystallization of slightly soluble salts from high 
ionic strength solutions (I = 0.15 for blood serum and 0.33 for 
urine). The relevant salts, calcium and magnesium phosphates, 
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FIGURE 1. 
After ref. (14).General 24h precipitation diagram of the calcium phosphate system, showing the solubility boundary and the 
regions of direct crystal growth (A) and crystallization via precursor phases (B). In region B the initial precursor phase was 
amorphous calcium phosphate (ACP). The data, expressed in terms of the mean activity product vs. pH have been recalculated 
from precipitation diagrams of the system: CaCl2 – HPO4 – 0.15 M NaCl obtained at 37
0C and initial pH 7.4, 7.0, 6.5, 6.0 and 
5.0 (15, 16). 
SLIKA 1. 
Prema ref. (14). Opći taložni dijagram kalcijevih fosfata dobiven nakon 24 sata. Naznačene su granica topljivosti te granica 
između područja direktnog kristalnog rasta (A) i područja kristalizacije preko prekursorske faze (B). U području B početna 
prekursorska faza bila je amorfni kalcijev fosfat (ACP). Podaci, izraženi kao prosječni produkti aktiviteta u ovisnosti o pH 
preračunati su iz taložnih dijagrama sustava : CaCl2 – HPO4 – 0.15 M NaCl dobivenih pri 37
0C i početnim pH 7.4, 7.0, 6.5, 6.0 
i 5.0 (15, 16).
calcium oxalates, uric acid and urates appear as different crystal 
hydrates, which are likely to undergo phase transformation 
and/or aggregation processes. The thermodynamics 
and kinetics of crystallization processes depend on the 
experimental conditions (reactant concentrations, pH, ionic 
strength, temperature, time of aging, additives). Thus the 
first approach might be to construct adequate precipitation 
diagrams to map the properties of precipitates formed at 
specified times as functions of the experimental conditions, 
while in the next step one should learn about the kinetics 
of crystallization in specified systems. In the Laboratory 
for Precipitation Processes at the Rudjer Boskovic Institute 
precipitation diagrams were used to study the properties of 
biomineral and urinary salts precipitating from solutions at 
biologically relevant pH, temperature and ionic strength. The 
following systems were investigated: calcium phosphates (14-
16, 18), (calcium oxalates (17, 18), magnesium phosphates 
(struvite and newberyite, (19, 20)), uric acid, sodium and 
calcium urates (21, 22). 
A general precipitation diagram of the calcium phosphate 
system, in which the precipitation boundaries are defined by the 
mean ion activity products and the pH is shown in Fig. 1 (after 
ref. (14)). It shows that the mechanism of crystallization (and 
consequently the composition and structures of the emerging 
solid phases) are pH dependent, the critical transition region 
lies between pH 6 and 7. 
Two precipitation regions are defined: A region of direct 
precipitation (region A) and, at higher ionic products and 
higher pH values, a region of crystallization via precursor 
phases (region B). At pH > 7.5 region B is prevailing in the 
whole concentration range. The data used in Fig. 1 are from 
precipitation diagrams constructed at different constant initial 
pH values (15, 16), which show that in region A the prevailing 
crystal phase is calcium hydrogenphosphate dihydrate, 
DCPD, presumably formed by heterogeneous nucleation 
upon solution impurities. At higher activity products and pH 
> 6 (region B) the first precipitate formed was amorphous 
calcium phosphate (ACP) (16), which later transformed 
into octacalcium phosphate (OCP) and/or calcium deficient 
apatite, DA. These findings are in accordance with kinetic 
data (23- 25). The number of particles recorded in region B 
is in the range found for precipitates formed by homogeneous 
nucleation (ref. (14), for details about heterogeneous and 
homogeneous nucleation see also ref. (26)).
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FIGURE 2. 
Schematic presentation of a kinetic precipitation experiment. Upper diagram represents experimental data plotted in terms of 
ά vs time or Vt vs. time curves from which the rate vs supersaturation curve (lower diagram) is recalculated according to equ. 
1. Sections A, B and C correspond in time and indicate time periods in which nucleation (A), crystal growth (B) and crystal 
growth inhibited by aggregation (C) are rate controlling. After ref. (28).
SLIKA 2. 
Shematski prikaz kinetičkog taložnog eksperimenta. Na gornjem dijagramu prikazani su eksperimentalni podaci kao krivulje 
ά ili Vt u ovisnosti o vremenu iz kojih je krivulja brzina u ovisnosti o presićenju (donji dijagram) preračunata prema jednadžbi 
1. Područja A, B, C označavaju vremena u kojima su nukleacija (A), kristalni rast (B) i kristalni rast inhibiran agrgacijom (C) 
stupnjevi koji kontroliraju brzinu. Prema ref. (28).
Further efforts have been concentrated to study the kinetics 
of precipitation and phase transformation in some of the most 
relevant systems in physiological mineralization (i.e. the 
calcium phosphate system, refs (24, 25, 27)) and in urolithiasis 
(i.e. calcium oxalates, refs (27 – 29) and magnesium 
phosphates (30)). It was possible to construct kinetic diagrams 
of spontaneous precipitation systems, by which subsequent 
precipitation processes (nucleation, crystal growth, growth and 
aggregation) could be resolved in time (27, 28). A schematic 
presentation of the procedure is shown in Fig. 2 (after ref. 
(28)). From experimental kinetic data (upper diagram) the rate 
of precipitation R has been calculated according to equation 
(1) and plotted as a function of the supersaturation to a given 
salt (lower diagram in Fig 2). 
R = (dά/dt) ά -2/3 = kN1/3Sp                                 (1)
where S is the supersaturation, N is the number of particles 
per cm3, k is a proportionality constant and p is the order of 
the reaction. 
The degree of the reaction, ά is defined in terms of the reactant 
concentrations, c or the precipitate volume V as
ά = (ct – cs)/(co – cs) = Vt / Vmax                         (2)
In equation (2) co , cs and ct are solute concentrations at zero 
time, time t and at equilibrium, respectively, while Vt and  Vmax 
are the precipitate volume at time t and at equilibrium.        
                
In such diagrams sections corresponding to the respective 
rate controlling processes could easily be distinguished (see 
Fig.2 and ref. (28)). The method has been applied to studies 
of precipitation of calcium oxalates from high ionic strength 
solutions and the influence of additives thereon (27 - 29).
 
The kinetics of ACP to crystalline phase transformation is 
shown in Figs. 3 and 4 (after ref. (24, 25, 40)). In Figure 3 
the process is visualized by electron micrographs, while the 
corresponding kinetic curve in Fig 4 shows regions of ACP 
metastability (A) followed by fast secondary crystal growth at 
the surfaces of ACP particles (B) and a region of ripening and 
phase transformation on expense of the remaining amorphous 
material (C). Under the specific conditions of precipitation 
ACP converted into octacalcium phosphate within 24h (Fig. 
3). A kinetic parameter, the induction time, ti i.e. the time 
needed for the onset of secondary precipitation, could be 
defined as shown in Fig. 4. 
2.2. Promoters and inhibitors - the multiple roles of additives 
in crystallization.  For the materials scientist two important 
conclusions emerge from section 1: 
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FIGURE 3. 
Electron micrographs and corresponding electron diffraction patterns of amorphous calcium phosphate (ACP) particles, initial 
crystallization upon an ACP particle and aggregates of octacalcium phosphate (OCP) crystals observed 24h after sample 
preparation. After (24, 45).
SLIKA 3. 
Elektronske mikrografije i odgovarajuće difrakcijske slike elektrona čestica amorfnog kalcijevog fosfata (ACP), početne 
kristalizacije na česticama ACP i agregata kristala oktakalcijevog fosfata (OCP) dobivenih nakon 24 sata od pripreme sustava. 
Prema (24, 45).
•  Both physiological and pathological mineralization may be 
seen as crystallization upon and/or within an organic matrix.
•  In both processes the presence or deficiency of promoters 
and/or inhibitors of crystallization is critical.
In physiological mineralization (i. e. bone and tooth 
formation) the collagen and/or amelogenin matrices provide 
a framework for mineralization while non-collageneous 
acidic and/or phosphorylated matrix macromolecules are 
involved in the control of nucleation, crystal growth and 
phase transformation of the mineral phase (1 – 4). In some 
forms of pathological mineralization, such as kidney stone 
formation, crystals are originally generated in the body fluid, 
then attach to the “organic matrix” (i.e. to defective parts of 
the kidney walls) and proceed growing and aggregating into 
an urolith (11 – 13). As in physiological mineralization, at all 
stages of urolith formation the presence or absence of small 
and macromolecular inhibitors / promoters in the matrix and/
or the body fluid (the urine) is a controlling factor.
It has been shown by numerous examples, including 
examples relevant to biomineralization and urolitiasis 
(31, 32) (see also M. Dutour Sikirić, V. Babić-Ivančić and 
N. Filipović-Vinceković in this volume) that small and 
macromolecular inhibitors/promoters can influence every step 
of the crystallization process, i.e. they can promote or inhibit 
heterogeneous nucleation, retard crystal growth and/or induce 
habit modification, stabilize metastable phases and inhibit 
or promote aggregation of crystals or amorphous precursor 
phases. Of special interest for this treatise, because of their 
relevance to physiological and pathological mineralization, 
are organic – inorganic interactions in the calcium oxalate 
(33 – 38) and calcium phosphate (39 - 45) crystallization 
systems. Here we discuss but one example, the influence of 
polyelectrolytes on the phase transformation of ACP in high 
ionic strength solutions (45).
 
The role of ACP as precursor in calcium phosphate 
crystallization has been discussed in section 2.1 and its 
involvement in some forms of biomineralization has been 
demonstrated by other authors (8). When ACP transforms into 
crystalline phases (octacalcium phosphate, calcium deficient 
hydroxyapatite) the induction time, ti and the structure of the 
ensuing solid phase depend on the experimental conditions 
(pH, reactant concentrations, ionic strength, concentrations of 
additives). Using the kinetic parameter, ti (i.e. the time elapsed 
before the onset of secondary precipitation) as a criterion 
(Figs. 4, 5) it was possible to explore the influence of additives 
on ACP – apatite phase transformation (45). 
As an example the influence of increasing concentrations 
of high and low molecular weight poly-L-glutamate (PGA) 
39
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 FIGURE 4.  
pH vs time curve representing the formation and phase transformation of amorphous calcium phosphate (ACP). Sections A, 
B and C correspond to the respective electron micrographs in Fig. 3. A – metastable region of ACP particles, B – secondary 
precipitation. New crystals form at the surfaces of the ACP particles. C – region of solution mediated crystal growth on 
account of the amorphous material. The kinetic parameter, ti (time of metastability of ACP or induction time elapsed before the 
onset of secondary precipitation) is marked with an arrow. After ref. (45).
SLIKA 4. 
Krivulje pH u ovisnosti o vremenu nastajanja i fazne transformacije amorfnog kalcijevog fosfata (ACP). Odgovarajuće 
elektronske mikrografije taloga nastalog u područjima A, B, C prikazane su na slici 3. A- metastabilno područje čestica ACP, 
B – sekundarno taloženje. Novi kristali nastaju na površini čestica ACP. C – područje kristalnog rasta putem otopine na 
račun amorfnog materijala. Kinetički parametar, ti (vrijeme metastabilnosti ACP ili vrijeme indukcije proteklo prije početka 
sekundarnog taloženja) označen je strelicom. Prema referenci (45).
and poly-L-lysine (PLL) on ti is shown in Fig. 5 (after ref. 
(45)). When the values of ti are plotted as a function of the 
polymer concentration the dual effect of the molecules 
becomes apparent – at low concentrations the polymers act as 
promoters, while at higher concentrations they act as inhibitors 
of phase transformation of ACP. 
A schematic presentation of likely mechanisms of these effects 
is shown in Fig. 6 (after ref. (45)). Induction and inhibition 
of crystal nucleation at the surfaces of ACP particles may be 
explained as follows: At low concentrations polyelectrolyte 
molecules adsorb in random conformation and the adsorption 
process is reversible. Since the adsorbed molecules can 
overcharge the ACP particles, and also inhibit aggregation, a 
large number of small, highly charged particles is created, (see 
also ref. (41)), which concentrate oppositely charged Ca2+ and/
or HPO4
2- ions and thus provide effective sites for secondary 
nucleation and crystal growth (Fig. 6A). On the other hand, 
at high concentrations polymer molecules spread until they 
completely envelop the amorphous particles (Fig. 6B) 
thus hindering the transport of ions to the template surface, 
consequently delaying or completely hindering nucleation of 
the secondary precipitate. This effect was especially strongly 
expressed in the presence of poly-L-glutamate (45). 
The findings are consistent with other studies of the behavior 
of polyelectrolytes in inorganic precipitation systems (31). 
Another interesting example is the study of the effect of 
polyglutamic acid, polylysine and heparin on the crystallization 
of calcium oxalate (46). In this experiment the authors show 
that by far the most efficient retardation is achieved with 
polyglutamate, but the addition of a specific low concentration 
of the polymer greatly enhanced the nucleation rate in the 
same crystallization system. It might be possible to envisage 
a mechanism similar to the one outlined above (Fig. 6.) in this 
case as well.
3. Applied interdisciplinary research
The results described in this section have been obtained by 
interdisciplinary teams, involving MD’s, physical, analytical 
and clinical chemists, cell biologists and their laboratories. 
Because of the complexity of the systems involved, the 
research could not have been accomplished without a strictly 
interdisciplinary approach.
3.1. Methods for discriminating between calcium stone 
formers and healthy individuals. The formation of kidney 
stone is an extremely complex process, some aspects of 
which have been discussed above (Sections 1.3 and 2.2.). 
In the eastern continental region of Croatia (Osijek and 
surroundings) calcium oxalate monohydrate, (COM) stones, 
apatite stones and their mixtures were most frequently found 
(12). From metabolic analysis the following risk factors for 
calcium stone formation have been identified (12, 47): (a) 
Hypercalciuria, hyperoxaluria and high pH, which determine 
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FIGURE 5. 
Plots of ti as a function of the polyelectrolyte concentration for amorphous calcium phosphate (ACP) phase transformation in 
the presence of A – high and low Mw poly-L-glutamate and B – high and low Mw poly-L-lysine. The horizontal dotted lines 
correspond to ti in the control system without polyelectrolyte. Values of ti  < ti(control) indicate induction and ti > ti(control) 
show inhibition of secondary precipitation (marked on the diagrams). After ref. (45).
SLIKA 5. 
Grafovi ovisnosti ti o koncentraciji polielektrolita za faznu transformaciju amorfnog kalcijevog fosfata (ACP) u prisutnosti 
A – poli-L-glutamata visoke i niske molekulske težine i B – poli-L-lizina visoke i niske molekulske težine. Vrijednosti ti  < 
ti(kontrola) ukazuju na indukciju, a ti > ti(control) pokazuju inhibiciju sekundarnog taloženja (označeno na grafovima). 
Prema  (45).
the supersaturation of the urine to the critical urinary salts 
and (b) a lack of inhibitors, i.e. a high Ca/citrate ratio (a 
consequence of hypocitrateuria, (12)) and low concentrations 
of acid mucopolysaccharides (AMPS (47)). Complicating 
diagnoses based on metabolic factors is also the dual role 
of organic molecules as promoters and/or inhibitors of 
crystallization (see Section 2.2). A practical way to circumvent 
these difficulties and to enable relatively quick analysis in a 
clinical Laboratory is the determination of the risk of stone 
formation in whole urine. Three simple chemical methods to 
distinguish between stone formers and healthy individuals 
have been developed (48, 49). Two of the methods are based 
on overnight precipitation from the test urines (48). In the first 
method (method A) precipitation was initiated by the addition 
of COM seed crystals, while in the second method (method B) 
the concentrations of calcium and oxalate in unseeded urine 
were adjusted to equal, predetermined values. After overnight 
incubation the differences in calcium concentrations between 
unseeded and seeded urine (A) and of total and residual soluble 
calcium concentrations (B) were analytically determined. 
The analysis was carried out for urines of stone formers and 
healthy individuals and impressive differences were obtained, 
showing that stone formers lack inhibitors of precipitation 
that are present in urines of non-formers. The third method 
(49) is based on the determination of the calcium binding 
capacity (CBC) of whole urine by titration of early morning 
urine with a calcium chloride solution. For this purpose a 
calcium selectrode with a disposable membrane, which can 
be prepared and replaced in the laboratory, was used. Plots of 
the calcium ion concentration versus the concentration of total 
(added) calcium were linear up to a point, where precipitation 
of calcium salts commenced. The slopes of such titration 
lines are inversely proportional to the CBC and are therefore 
indicative of the amount of calcium complexing molecules 
in the urine. Thus synthetic urine-like solutions, if devoid of 
calcium binding matter, should give titration curves with the 
slope of 1. In the experiments described in (49) titration curves 
of healthy subjects had slopes of 0.2 – 0.3 in contrast to stone 
forming urines, with slopes of titration curves of 0.5 – 0.8. 
Statistical evaluation gave mean values of 0.31 for healthy 
urines (13 samples) and 0.64 for stone formers (26 samples). 
There was good correlation with the clinical situation as well.
3.2. Materials for the replacement and/or repair of bone and 
teeth: 
To alleviate the problem of osteointegration of metals, 
differently prepared surface coatings consisting of calcium 
phosphates have been applied. Coating methods involving the 
immersion of pretreated material into “simulated body fluid” 
(i.e. a solution containing the inorganic constituents of blood 
serum, (see Table 2.) have attracted attention (9, 50).
In the course of international collaborations between materials 
scientists, cell biologists, dentists and medical doctors, a new 
class of biomimetic organic-inorganic composite coatings has 
been designed in our laboratories (refs. (51, 52) see also M. 
Dutour Sikirić, V. Babić-Ivančić and N. Filipović-Vinceković 
in this volume). In the design we tried to mimic the basic 
strategy by which mineral is deposited in some forms of 
biomineralization, i.e. to first lay down an organic matrix, 
which is then mineralized in stages through the deposition of 
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FIGURE 6.  
Schematic presentation of amorphous calcium phosphate (ACP) particles formed in the presence of negatively charged 
polyelectrolyte. A – induction of secondary precipitation at low polyelectrolyte concentration, B – inhibition of secondary 
precipitation at high concentration of polyelectrolyte. After ref. (45).
SLIKA 6. 
Shematski prikaz čestica amorfnog kalcijevog fosfata (ACP) nastalih u prisutnosti negativno nabijenog polielektrolita. A – 
indukcija sekundarnog taloženja pri niskim koncentracijama polielektrolita, B – inhibicija sekundarnog taloženja pri visokim. 
koncentracijama polielektrolita. Prema ref. (45).
poorly crystallized mineral and subsequent maturation (see 
Section 1.1 and ref. (8)). 
In these experiments the organic matrix consisted of PLL/
PGA multilayers (for polyelectrolyte multilayer design see ref 
(52)) into which layers of ACP particles were incorporated. 
The assembly was then immersed into a metastable calcifying 
solution, thus enabling ACP phase transformation and crystal 
growth “in situ” within the organic matrix. The rough crystal 
surfaces obtained were then smoothened by adding a final 
(PLL/PGA)5 multilayer, thus enabling good attachment and 
proliferation of bone forming cells. The coatings have been 
tested by extensive cell culture tests and by a validated “in 
vivo” pull-out model in rabbit tibia with uncoated chemically 
etched titanium plates serving as controls (51). The results 
of both “in vitro” and “in vivo” experiments show excellent 
biological properties of the coated titanium plates. Thus, when 
tested in the animal experiment, the coating significantly 
enhanced the attachment of titanium implants to the bone as 
compared to uncoated titanium plates, with more than twice 
the force needed to detach coated implants.
The above described organic-inorganic composite coatings 
have several advantages:
•	The deposition of polyelectrolyte multilayers is largely 
independent of the type and topology of the substrate. It 
is thus possible to apply the coatings to a wide variety of 
bioinert implant materials of different shapes and sizes.
•	Bioactive molecules can be co-adsorbed into the organic 
matrix or coprecipitated with the inorganic phase without 
loosing their bioactivity.
•	Because of “in situ” crystal growth of the inorganic phase 
the coating is tightly anchored to the substrate exhibiting 
satisfactory mechanical stability.
•	The coating procedure is simple, energy saving and 
environmentally friendly and could be easily up scaled for 
factory production. 
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U prvom dijelu ovog pregleda prikazali smo sličnosti i razlike između fiziološke i patološke biomineralizacije, tj. nastajanja 
kostiju i zubi, osteoartikularne i zubne patologije, te urolitijaze. Pojednostavljeno možemo ove procese smatrati taloženjem 
ionskih kristala iz otopina visoke ionske jakosti na i/ili unutar organske matrice. Prisutnost ili manjak promotora ili inhibitora 
kristalizacije u svim su slučajevima od izuzetne važnosti.  Međutim, dok je fiziološka mineralizacija strogo biološki kontrolirana, 
urolitijaza je uglavnom kontrolirana fizičko-kemijskim faktorima kao sto su prezasićenost urina, pomanjkanje inhibitora 
kristalizacije i agregacije, itd.
U drugom dijelu preglednog rada opisana su fizičko-kemijska istraživanja, izvedena zbog boljeg razumijevanja procesa 
biomineralizacije. Konstruirani su taložni dijagrami za sustave kalcij i magnezij fosfata, kalcij oksalata, mokraćne kiseline, te 
natrij i kalcij urata za slučaj taloženja iz otopina visoke ionske jakosti u biološki relevantnim uvjetima. Prikazan je generalni 
taložni dijagram kalcij fosfata sa granicom taloženja i granicom između područja, gdje kristali nastaju direktnim rastom i onim 
gdje nastaju putem transformacije prekusorske faze. Istraživanja kinetike taloženja prikazana su dijagramima, koje možemo 
interpretirati u smislu sukcesivnih ili paralelnih taložnih procesa, kao što su nukleacija, kristalni rast i agregacija. Kinetičkom 
studijom fazne transformacije amorfnog kalcij fosfata (ACP) u oktakalcij fosfat i/odn. apatit pokazali smo, da makromolekule, 
kao što su poli-L-glutamat i poli-L-lisin mogu imati dvostruko djelovanje, tj kada su prisutne u niskoj koncentraciji djeluju kao 
promotori, a u visokim koncentracijama kao inhibitori sekundarnog taloženja kristalne faze na površini amorfnih čestica.
U trećem dijelu pregleda opisana su primijenjena interdisciplinarna istraživanja. Razrađene su tri kemijske metode za testiranje 
inhibitorskog potencijala nerazrijeđenog urina. Metode su jednostavne i pogodne su za primjenu u kliničkim laboratorijima za 
razlikovanje urina pacijanata s urolitijazom od urina zdravih osoba.
U posljednje vrijeme pripremljene su nove vrste organsko – anorganskih kompozita. kao presvlake za bioinertne metalne 
implante. Postupak pripreme uključuje „in situ” rast kristala kalcij fosfata unutar organsko - anorganske matrice (anorganska 
komponenta je ACP), koja je ranije adsorbirana na metalnu površinu. Tako pripremljene presvlake čvrsto prianjaju uz površinu 
supstrata i imaju izvrsna biološka svojstva, što smo provjerili „in vitro” i „in vivo” biološkim testovima.
ključne riječi: Agregacija; Amorfni kalcijev fosfat – kemija; Biomineralizacija; Fazna transformacija; Inhibitori; 
Interdisciplinarna istraživanja; Kinetike taloženja; Kristalizacija; Organsko-anorganske kompozitne presvlake; Promotori; 
Taložni dijagrami; Urolitijaza – mokraća, patologija, prevencija & kontrola
